3D-Printed Biosensors Market Size to Grow At 10.5% CAGR From 2023 to 2028

3D-Printed Biosensors Market Analysis (2023 - 2030)

The 3D-printed biosensors market has been growing at a substantial pace in recent years due to the increasing demand for advanced medical devices and the growing need for personalized medicine. Biosensors are devices that use biological recognition elements to detect analytes. 3D printing technology has enabled the creation of highly intricate and sophisticated devices that can perform a wide range of functions. The market is anticipated to continue growing as the demand for advanced medical devices increases and new applications are developed in the near future.

The COVID-19 pandemic has had a major impact on the 3D-printed biosensors market, as the demand for medical devices has skyrocketed. With the rapid spread of the virus, hospitals and other healthcare facilities have been struggling to keep up with the demand for testing and diagnostic equipment. This has created a huge demand for biosensors that can detect the presence of COVID-19 and other pathogens leading to a surge in demand for 3D-printed biosensors globally.

The 3D-printed biosensors market is constantly evolving with new research and developments with advancements taking place on a regular basis. In recent months, there have been several key developments in the market including the growing use of 3D printing technology in the development of wearable biosensors. These devices can be worn on the skin and provide continuous monitoring of a wide range of biological parameters, such as heart rate, oxygen levels, and glucose levels. This has the potential to revolutionize the way that medical professionals monitor patients enabling them to make more accurate diagnoses and provide more effective treatments. Furthermore, the increasing capital investments in the healthcare industry have been proven to be a positive step in augmenting the global market size and making the existing healthcare infrastructure more robust.

Another major development in the 3D-printed biosensors market is the use of 3D printing technology to create implantable biosensors. These devices can be implanted directly into the body and provide continuous monitoring of vital signs and other parameters helping to ensure that patients receive the care they require when they need it. This technology has the potential to transform the way that medical professionals approach patient care, enabling them to provide more proactive and effective treatment plans.

KEY MARKET INSIGHTS:

• The wearable biosensors segment is anticipated to grow at the fastest rate, with a CAGR of 16.1% between 2023 and 2028, due to the growing demand for wearable medical devices that can provide continuous monitoring of patients.
• The implantable biosensors segment is anticipated to grow at a CAGR of 13.4% between 2023 and 2028, due to the increasing demand for devices that can be implanted directly into the body to provide continuous monitoring of vital signs and other parameters.
• The metal extrusion technology accounted for the biggest market share for 3D-printed biosensors in 2022, and it is anticipated to expand at a CAGR of 9.7% from 2023 to 2028. Compared to other printing methods like material jetting and vat photopolymerization, metal extrusion 3D printing is more accurate, subtle, and user-friendly.
• In 2022, Asia-Pacific accounted for up to 39% of the global market for 3D-printed biosensors. Due to its significant application in the medical & healthcare industry for illness detection, 3D-printed Biosensors such as electrochemical, nanomechanical, and piezoelectric are in high demand and growing continuously in the region. The prevalence of chronic diseases like diabetes is rising significantly in developed nations like China, India, and Japan. For instance, since 2009, the prevalence of diabetes has increased, reaching 8.9% in India and 10.9% in China, according to a data from the International Diabetes Federation. The same survey also predicted that by 2030, India will have 101 million cases of diabetes and China will have 140 million cases, up from 77 million cases at the current time. With such a large number of diabetes patients, India and China will experience a rise in demand for 3D-printed Biosensors for disease detection and diagnosis, which will favourably impact the development of the 3D-printed Biosensors market in the Asia-Pacific region.
• Companies playing a leading role in the global 3D-printed biosensors market profiled in this report are Allevi Inc., Advanced Solutions Life Science, Cellink, Cyfuse Biomedical, Aspect Biosystem Ltd., OmniVision Technologies, Nano3d Bioscience Inc., Digilab Inc, Regenovo Biotechnology Co. Ltd., Organovo Holdings Inc.

MARKET SEGMENTATION:

By Type –

• Electrochemical Biosensors
• Piezoelectric Biosensors
• Nanomechanical Biosensors
• Optical Biosensors
• Thermometric Biosensors
• Wearable Biosensors
• Enzyme Biosensors
• Immunosensors

By Wearing Type –

• Wearable
• Non-Wearable

By Technology –

• Material Extrusion
• Vat Photopolymerization
• Material Jetting

By Application –

• Food Processing
• Pathogen Detection
• Disease Diagnosis
• Toxicity Detection

By End-Use Industry –

• Food & Beverage
• Medical & Healthcare
• Agriculture

By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

For More Info, Request Sample Copy Of This Report @